CMET-12. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS

INTRO/OBJECTIVE: Immune checkpoint inhibitors (ICI) have improved outcomes in a subset of patients with lung cancer. However, data describing the efficacy of ICI in lung cancer brain metastasis (LCBM) is limited. We analyzed overall survival (OS) in patients with LCBM treated with upfront ICI, defin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Barnett, Addison, Lauko, Adam, Li, Hong, Ali, Assad, Sagar, Soumya, Chao, Samuel, Pennell, Nathan, Peereboom, David, Stevens, Glen, Angelov, Lilyana, Yu, Jennifer, Murphy, Erin, Mohammadi, Alireza, Suh, John, Barnett, Gene, Ahluwalia, Manmeet
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
CNS Metastasis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847941/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.213
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items